1360553-19-0

Basic information

• Product Name: C₃₉H₃₃N₇O
• Synonyms: C₃₉H₃₃N₇O
• CAS NO: 1360553-19-0
• Molecular Weight: 615.737
• Mol File: 1360553-19-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₃₉H₃₃N₇O(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₉H₃₃N₇O(1360553-19-0)
• EPA Substance Registry System: C₃₉H₃₃N₇O(1360553-19-0)

Safety Data

• Hazardous Substances Data: 1360553-19-0(Hazardous Substances Data)

Upstream product

• 1360552-04-0 2-[4-(2-aminopyrimidin-5-yl)phenyl]-2-cyclopropyl-N-hydroxypropionamidine 
• 191103-80-7 1H-1-triphenylmethylimidazole-4-carboxylic acid 

Downstream Products

• 1360553-20-3 C₂₀H₁₉N₇O 
• 1360550-94-2 5-(4-{1-cyclopropyl-1-[5-(3-oxetan-3-yl-3H-imidazol-4-yl)-[1,2,4]oxadiazol-3-yl]-ethyl}-phenyl)-pyrimidin-2-ylamine 
• 1360550-95-3 5-(4-{1-cyclopropyl-1-[5-(1-oxetan-3-yl-1H-imidazol-4-yl)-[1,2,4]oxadiazol-3-yl]-ethyl}-phenyl)-pyrimidin-2-ylamine 

Relevant articles and documents

OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION FOR COMBINATION THERAPY

The present invention relates to combination therapy using compound of formula (I): or pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein and an additional pharmaceutically active agent. The invention also relates to pharmaceutical compositions comprising these combinations, and methods of using these combinations in the treatment of various diseases and disorders.